US Bancorp’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9 Hold
2
﹤0.01% 4148
2026
Q1
$8 Hold
2
﹤0.01% 4158
2025
Q4
$7 Hold
2
﹤0.01% 4027
2025
Q3
$28 Hold
2
﹤0.01% 3982
2025
Q2
$38 Hold
2
﹤0.01% 4129
2025
Q1
$22 Sell
2
-1
-33% -$12 ﹤0.01% 4165
2024
Q4
$42 Sell
3
-346
-99% -$4.32K ﹤0.01% 4124
2024
Q3
$3.55K Buy
349
+346
+11,533% +$10.3K ﹤0.01% 3666
2024
Q2
$146 Hold
3
﹤0.01% 3920
2024
Q1
$113 Hold
3
﹤0.01% 3921
2023
Q4
$206 Sell
3
-187
-98% -$15.2K ﹤0.01% 3904
2023
Q3
$31K Buy
190
+37
+24% +$8.73K ﹤0.01% 2673
2023
Q2
$50.2K Sell
153
-12
-7% -$3.66K ﹤0.01% 2493
2023
Q1
$45.6K Buy
165
+14
+9% +$5.14K ﹤0.01% 2571
2022
Q4
$58.5K Sell
151
-120
-44% -$33.8K ﹤0.01% 2446
2022
Q3
$65K Buy
271
+98
+57% +$26.2K ﹤0.01% 2398
2022
Q2
$38K Sell
173
-8
-4% -$3.44K ﹤0.01% 2733
2022
Q1
$123K Buy
181
+134
+285% +$80.6K ﹤0.01% 2199
2021
Q4
$32K Buy
47
+14
+42% +$10.4K ﹤0.01% 2870
2021
Q3
$24K Buy
+33
New +$22.5K ﹤0.01% 3039

Other funds holding OM

US Bancorp's OM Position: Q2 2026 in Review

US Bancorp held its Outset Medical (OM) position steady in Q2 2026 at 2 shares worth $9. The position accounts for ﹤0.01% of the portfolio, ranked #4148.

US Bancorp first reported a position in OM in Q3 2021 and has held it in 20 quarters since. The position peaked at $123K in Q1 2022. 93 funds tracked by Wall St. Rank hold OM as of Q2 2026.

  • US Bancorp held 2 shares of Outset Medical worth $9 as of Q2 2026.
  • US Bancorp left its Outset Medical share count unchanged in Q2 2026.
  • Outset Medical made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #4148 holding.
  • US Bancorp first reported a position in Outset Medical in Q3 2021 and has held it in 20 quarters since.
  • US Bancorp's Outset Medical position peaked at $123K in Q1 2022.
  • 93 funds tracked by Wall St. Rank held Outset Medical as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.